South Africa Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

South Africa Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Summary

GlobalData, the industry analysis specialist, has released its latest report: “South Africa Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape”. The report is an essential source of information on the analysis of the healthcare, regulatory and reimbursement landscape in South Africa. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The South African pharmaceutical market is the drug market with the most potential in Africa, followed by Egypt, Nigeria, and Kenya. The key factors responsible for driving the pharmaceutical market of South Africa are growing and ageing population, larger prevalence of chronic diseases, expanding private health insurance coverage, and increased patient volumes for general practitioners and specialist medical practitioners. In South Africa as of April 2022, approximately 276 companies are licensed by the Department of Health and the Medicine Control Council to manufacture, import, export or distribute pharmaceuticals. Domestic manufacturing pharmaceutical companies almost exclusively produce generic products thus making the pharmaceutical market import dependent. South Africa is the primary business hub for the medical device industry in sub-Saharan Africa. According to pharmaceutical report 2020, nearly every therapeutic class has at least one generic equivalent available and sales of OTC generics also surpass brand name products by almost ZAR1 billion ($6.4 billion) in value and more than 53 million units. The government launched National Development Plan (NDP) 2030 and National Strategic Plan 2017-22 to achieve universal healthcare and improve the healthcare system. These plans also aim to eradicate acquired immunodeficiency syndrome (AIDS), TB, and malaria, and enhance quality of life by reducing disease burden in South Africa.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in South Africa, and includes -

• An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
• Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Roche, Novartis, Sanofi, and Aspen
• Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Kimberly Clark, GE healthcare, and Getinge.
• An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, Healthtech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
• Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure.
• An overview of the opportunities for and challenges to growth in the South Africa’s healthcare market.

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

• Develop business strategies by understanding the trends shaping and driving the South Africa healthcare market
• Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the South Africa healthcare market in the future
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
• Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership